Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Indywidualna Specjalistyczna Praktyka Lekarska Agnieszka Remlinger-Molenda

Poland ul. Szkółkarska 32, 62-002 Suchy Las, Poland

  • 1 trial recruiting
  • Major depression · Anhedonia
  • Adult patients

About Specializations

Indywidualna Specjalistyczna Praktyka Lekarska Agnieszka Remlinger-Molenda in Suchy Las, Poland specialises in clinical trials of conditions such as Major depression, Anhedonia, and other specialisations. This site conducts important research.

Main research areas of the site

Psychiatry and Mental Health

The medical center is at the forefront of psychiatry and mental health research, focusing on innovative treatments for Major Depressive Disorder (MDD). The center's research is dedicated to exploring novel therapeutic approaches that address the complex neurobiological mechanisms underlying depression.

  • Major Depressive Disorder
  • Kappa Opioid Receptor Antagonists
  • Innovative Pharmacotherapy

By investigating the efficacy of new compounds such as NMRA335140, the center aims to enhance treatment outcomes for individuals suffering from MDD, offering hope for improved quality of life through advanced pharmacological interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Szkółkarska 3262-002 Suchy LasPoland
Open in maps ↗
Recruiting now
1 trial
Conditions studied
2

More sites in Suchy LasPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Major depression

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Citalopram
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Major depression

Not recruiting
InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International

Major depression+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.

Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Not recruiting
InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.

Major depression

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen - Cilag International
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.